| Valdimarsdottir, Heiddis |
Icahn School Of Medicine At Mount Sinai
United States |
Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Symptom Burden among Multiple Myeloma Patients undergoing Autologous Stem Cell Transplantation |
5R01CA260961-04 |
PAR-21-035 (R01 Clinical Trial Required) |
Marjorie Perloff, M.D. |
| Flynn, Kathryn E |
Medical College Of Wisconsin
United States |
Symptom Monitoring using Patient-Reported Outcomes to Optimize Medication Use (SyMPTOM) |
5R01CA285925-02 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Blanke, Charles D. |
Oregon Health & Science University
United States |
SWOG NCORP Research Base |
3UG1CA189974-11S1 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Lehto, Rebecca H |
Henry Ford Health + Michigan State University Health Sciences
United States |
Support for bereaved friend and family caregivers of cancer patients |
1R03CA282943-01A1 |
|
Brennan Streck, Ph.D., RN, M.P.H. |
| Castilla, Lucio H. |
Univ Of Massachusetts Med Sch Worcester
United States |
Study of tyrosine kinase inhibitors as preventive therapy in RUNX1-FPD |
1U01CA296350-01 |
|
Marjorie Perloff, M.D. |
| Yaghjyan, Lusine |
University Of Florida
United States |
Stromal contributions to breast carcinogenesis |
5R01CA277817-03 |
|
Christos Patriotis, Ph.D., M.Sc. |
| Tamkus, Deimante |
Cook County Health And Hospital System
United States |
Stroger Hospital of Cook County (SHCC) NCORP |
3UG1CA190000-12S1 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| John, Esther M. |
Stanford University
United States |
Stress, inflammation, and health-related quality of life of long-term breast cancer survivors |
1R21CA290430-01 |
|
Brennan Streck, Ph.D., RN, M.P.H. |
| Hui, David |
University Of Tx Md Anderson Can Ctr
United States |
Strategies for Personalizing Oxygen and support Therapies for dyspnea in Oncology |
5R01CA288515-02 |
|
Brennan Streck, Ph.D., RN, M.P.H. |
| Acharya, Munjal M |
University Of California-Irvine
United States |
Stem cell-derived exosomes to ameliorate chemobrain |
5R01CA262213-03 |
PAR-21-329 (R01 Clinical Trial Optional) |
Rachel Altshuler, Ph.D. |
